Why Diabetes Stock Insulet Dropped 12% in October
Shares of Insulet (NASDAQ: PODD) declined 11.9% in October, according to data from S&P Global Market Intelligence. The S&P 500 returned 2.2% last month.
The Boston-area healthcare company is the leader in tubeless insulin pump technology with its Omnipod pump.
Image source: Getty Images.
Source Fool.com


